Testing effectiveness (Phase 2)Study completedNCT01997905What this trial is testingStroke Feasibility StudyWho this might be right forAtrial FibrillationAFib AtriCure, Inc. 13
Not applicableActive Not RecruitingNCT04479722What this trial is testingUsing Left Atrium Appendage Closure in NVAF Patients With High Risk of Ischemic StrokeWho this might be right forAtrial FibrillationStroke Shanghai MicroPort Medical (Group) Co., Ltd. 210
Not applicableLooking for participantsNCT05369195What this trial is testingCerebral Protection in Transcatheter Left Atrial Appendage OcclusionWho this might be right forAtrial FibrillationSilent StrokeCognitive Impairment+1 more Silesian Centre for Heart Diseases 240
Testing effectiveness (Phase 2)Study completedNCT04213807What this trial is testingA Dose-range Finding Study of MAA868 in Patients With Atrial FibrillationWho this might be right forAtrial Fibrillation Anthos Therapeutics, Inc. 28
Not applicableUnknownNCT03110627What this trial is testingIncreasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD LeadWho this might be right forCardiac ArrhythmiasAtrial Fibrillation and FlutterCardiovascular Diseases+1 more Unity Health Toronto 188
Post-approval studies (Phase 4)Study completedNCT02426944What this trial is testingLeft Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial FibrillationWho this might be right forAtrial Fibrillation Charles University, Czech Republic 400
Not applicableLooking for participantsNCT03710902What this trial is testingEmpowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic StrokeWho this might be right forIschemic StrokeTransient Ischemic AttackAtrial Fibrillation+2 more Jukka Putaala 405
Large-scale testing (Phase 3)Study completedNCT00403767What this trial is testingAn Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial FibrillationWho this might be right forAtrial FibrillationStrokeEmbolism Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 14,269
Not applicableStudy completedNCT02559232What this trial is testingAn Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care CentersWho this might be right forStrokePrevention and ControlAtrial Fibrillation Bayer 247
Not applicableStudy completedNCT04679987What this trial is testingIncidence of Paroxysmal Atrial Fibrillation (AF) in Patients With Acute Ischemic Stroke or Transient Ischemic Attacks (TIAs) by 48 Hours Holter MonitoringWho this might be right forTransient Ischemic Attack Helwan University 200
Not applicableStudy completedNCT03280641What this trial is testingD-dimer In Patients With atRial Fibrillation rEceiving antiCoagulation TherapyWho this might be right forAtrial FibrillationStrokes Thrombotic Wuhan Asia Heart Hospital 1,194
Early research (Phase 1)Ended earlyNCT01647620What this trial is testingA Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.Who this might be right forDeep Vein Thrombosis LegStroke (in Patients With Atrial Fibrillation) Diakron Pharmaceuticals 30
Post-approval studies (Phase 4)Looking for participantsNCT03862859What this trial is testingThe Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on DialysisWho this might be right forAtrial Fibrillation and FlutterStrokeMajor Bleed+1 more Nicholas Carlson 718
Not applicableUnknownNCT04396418What this trial is testingStroke Prevention and Rhythm Control Therapy STEEER-AFWho this might be right forAtrial Fibrillation European Society of Cardiology 1,732
Not applicableStudy completedNCT01606995What this trial is testingXarelto for Prevention of Stroke in Patients With Atrial FibrillationWho this might be right forAtrial Fibrillation Bayer 6,784
Not applicableWithdrawnNCT03804125What this trial is testingAdverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement SurgeryWho this might be right forCerebral StrokeThrombosis, Deep VeinPulmonary Embolism Pfizer
Not applicableStudy completedNCT02849509What this trial is testingPatient Convenience Study- NIS RELATEWho this might be right forAtrial Fibrillation Boehringer Ingelheim 1,313
Not applicableStudy completedNCT01468701What this trial is testingGLORIA-AF Registry Program - Second and Third PhasesWho this might be right forStrokeAtrial Fibrillation Boehringer Ingelheim 37,235
Not applicableStudy completedNCT03563937What this trial is testingReal-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Factor Xa Non-vitamin-K Oral Anticoagulants (NOACs) vs. PhenprocoumonWho this might be right forAtrial Fibrillation Bayer 64,920
Not applicableLooking for participantsNCT07295769What this trial is testingAtrial Fibrillation Detection Using MEMO Patch in Patients With Stroke of Unknown CauseWho this might be right forEmbolic Stroke of Undetermined Source Asan Medical Center 100